期刊文献+

中轴型脊柱关节炎诊断和治疗的专家共识(2019年版) 被引量:22

Consunsus on diagnosis and treatment of axial spondyloarthritis(2019 version)
原文传递
导出
摘要 一、制定背景脊柱关节炎(spondyloarthritis,SpA),或称脊柱关节病(spondyloarthropathies,SpAs),是一组慢性炎症性疾病,具有特定的病理生理、临床、放射学和遗传学特征。其显著特点是炎性腰背痛,伴或不伴有外周关节炎。这一类疾病包括:中轴型脊柱关节炎(axial SpA,ax-SpA)[包括强直性脊柱炎(ankylosing spondylitis,AS)和放射学阴性中轴型脊柱关节炎(non-radiographic axial SpA,nr-axSpA)]、反应性关节炎(reactive arthritis,ReA)/莱特综合征、银屑病关节炎(psoriatic arthritis,PsA)、炎症性肠病性关节炎(arthropathy of inflammatory bowel disease,IBD)、未分化脊柱关节炎(undifferentiated spondyloarthritis)、幼年型脊柱关节炎(juvenile spondyloarthritis)[1]。
作者 徐卫东
出处 《中华关节外科杂志(电子版)》 CAS CSCD 2019年第3期261-266,共6页 Chinese Journal of Joint Surgery(Electronic Edition)
  • 相关文献

参考文献3

二级参考文献33

  • 1预防骨科大手术深静脉血栓形成指南(草案)[J].中华骨科杂志,2007,27(10):790-792. 被引量:110
  • 2Rudwaleit M, Braun J, Sieper J. ASAS classification criteria for axial spondyloarthritis. Z Rheumatol, 2009, 68(7): 591-593.
  • 3Sieper J, Klopsch T, Richter M, et al. Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double- blind, controlled study. Ann Rheum Dis, 2008, 67(3): 323-329.
  • 4Song IH, Hermann K, Haibel H, et al. Effects of etanercept ver- sus sulfasalazine in early axial spondyloarthritis on active inflam- matory lesions as detected by whole-body MRI (ESTHER): a 48- week randomised controlled trial. Ann Rheum Dis, 2011, 70(4): 590-596.
  • 5van der Heijde D, Sieper J, Maksymowych WP, et al. 2010 Up- date of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis, 2011, 70(6): 905-908.
  • 6Takahiko H, Hiroki M, Terufumi S, et al. Transmembrane TNF- a:structure, function, and interaction with anti-TNF agents. Rhrumatology 2010;49:1215-1228.
  • 7Maksymowych WP. Update on the treatment of ankylosing spondylitis. Ther Clin Risk Manag, 2007, 3(6): 1125-1133.
  • 8Braun J, van den Berg R, Baraliakos X, et aL 2010 update of the ASAS/EULAR recommendations for the management of ankylos- ing spondylitis. Ann Rheum Dis, 2011, 70(6): 896-904.
  • 9Dougados M, Braun J, Szanto S, et al. Efficacy of etanercept on rheumatic signs and puhnonary function tests in advanced anky- losing spondylitis: results of a randomised double-blind placebn- controlled study (SPINE). Ann Rheum Dis, 2011, 70(5): 799-804.
  • 10Braun J, van der Horst-Bruinsma IE, Huang F, et al. Clinical ef- ficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a randomized, double-blind trial. Arthritis Rheum, 2011, 63(6): 1543-1551.

共引文献110

同被引文献193

引证文献22

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部